期刊文献+

14例胰岛素类似物过敏的病例报道及文献复习 被引量:3

Allergic reaction to insulin analogue:14 cases report and literature review
原文传递
导出
摘要 目的总结胰岛素类似物过敏的临床表现、治疗及预后,以期指导临床实践。方法总结我院2002年12月至2014年12月诊治的胰岛素类似物过敏病例14例,检索美国PubMed、荷兰Sciencedirect、CNKI和万方数据库,获得文献报道病例26例,分析临床特点、诊治过程及治疗与临床表现的关系。结果 38例提供过敏前胰岛素类似物使用时间,89.5%过敏发生在用药21d内。10例对多种胰岛素类似物过敏,2例发生全身过敏反应。提供治疗方案的39例,其中3例单纯抗过敏治疗,11例更换胰岛素,12例停用胰岛素,13例采用脱敏治疗。对治疗方案与过敏前胰岛素使用时间进行Spearman分析(r=0.441,P=0.006)。结论胰岛素类似物过敏多在应用后短期内发生,严重者威胁生命。过敏前的胰岛素使用时间对过敏后治疗方案的选择有提示作用。 Objective To explore the clinical characteristics,treatment and prognosis of allergic reaction to insulin analogue. Methods Clinical characteristics,treatment and the relationship between treatment and clinical characteristics were analyzed in 14 cases treated in our hospital during December 1,2002 to December 31,2014 and 26cases obtained from PubMed,Sciencedirect,CNKI and WANFANG DATA. Results The duration of insulin analogue treatment before allergic reaction were provided in 38 cases and the median time of the duration was 2.5days(0,450days).89.5% allergic reactions occurred within 21 days after insulin analogue initiation.10 patients suffered from allergic reaction to a variety of insulin analogues.General allergic reaction occurred in 2patients.39 patients reported their treatments on allergic reactions:insulin analogue was continued when anti-allergic drug applied in 3patients,changed in11 patients,and stopped in 12 patients,and desensitization of insulin was performed in 13 patients.Treatment of insulin allergy and duration of insulin treatment before allergy were analyzed by spearman analysis(r=0.441,P=0.006). Conclusion Most of allergic reactions occur within a short period after insulin analogue initiation.Some even are life-threatening.Awareness of duration of insulin treatment before allergic reaction will be helpful for treatment to allergy.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第9期832-835,共4页 Chinese Journal of Diabetes
关键词 胰岛素类似物 过敏反应 糖尿病 Insulin analogue Allergic reaction Diabetes mellitus
  • 相关文献

参考文献26

  • 1Yasuda H, Nagata M, Moriyama H, et al. Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care, 2001,24 : 2008-2009. 被引量:1
  • 2Barranco R, Herrero T, Tornero P, et al. Systemic allergic reac- tion by a human insulin analog. AIlergy,2003,58:536-537. 被引量:1
  • 3Takata H, Kumon Y, Osaki F, et al. The human insulin ana- logue aspart is not the almighty solution for insulin aller-gy. Diabetes Care, 2003,26: 253-254. 被引量:1
  • 4Darmon P,Castera V,Koeppel MC,et al. Type HI allergy to in- sulin detemir. Diabetes Care, 2005,28 : 2980. 被引量:1
  • 5Aujero MP, Brooks S, Li N, et al. Severe serum sickness-like type l]I reaction to insulin detemir. J Am Acad Dermatol, 2011,64:e127-e128. 被引量:1
  • 6P~rez E,Gonzdlez R, Martinez J, et al. Detemir insulin-induced anaphylaxis. Ann Allergy Asthma Immunol, 2009, 102: 174-175. 被引量:1
  • 7Stechemesser L, Hofmann M, Hawranek T, et al. Type m al- lergy to insulin detemir: response to darmon. Diabetes Care, 2006,29:2758. 被引量:1
  • 8B[umer I. Severe, delayed insulin detemir iniection site reac- tion. Diabet Med, 2008,25 : 1008. 被引量:1
  • 9"Blumer 1R. Severe injection site reaction to insulin detemir. Diabetes Care, 2006,29 :946. 被引量:1
  • 10Sola-Gazagnes A, Pecquet C, M'Bemba J, et al. Type I and type IV allergy to the insulin analogue detemir. Lancet, 2007,369: 637-638. 被引量:1

二级参考文献39

共引文献47

同被引文献15

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部